Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination therapy consists of five-flavor sophora flavescens enteric-coated capsules and glutamine, typically administered alongside warm-water sitz baths for the treatment of radiation-induced proctitis. The five-flavor sophora flavescens capsule is a Traditional Chinese Medicine (TCM) formulation containing *Sophora flavescens* (Kushen) as a primary ingredient, which is rich in alkaloids like matrine and oxymatrine known for their anti-inflammatory and mucosal-healing properties. Glutamine is an amino acid that serves as a critical metabolic fuel for enterocytes and colonocytes, supporting the repair and regeneration of the intestinal mucosa damaged by pelvic radiotherapy. This specific regimen is being evaluated in clinical trials led by Peking University First Hospital for patients exhibiting significant rectal toxicity (RTOG grades >2) following radiation treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on five-flavor sophora flavescens enteric-coated capsules + glutamine.